BioStar Ventures said yesterday that it raised $68 million for its BioStar III fund, its largest fund for the company to date. The funds are slated to be invested in medical technology companies with a focus on cardiovascular and orthopedic medicine, the Petoskey, Mich.-based company said. “Our business model is to engage world-renowned practicing physicians […]
December 3, 2014 by Brad Perriello
Trice Medical said it raised the 1st tranche of an $11.6 million Series B round and named medtech veteran Jeffrey O’Donnell Sr. as its new CEO.
Trice Orthopedics said it closed a bridge loan financing worth about $3 million.
The King Of Prussia, Pa.-based medical device company said BioStar Ventures led the round, along with Millennium Life Sciences, existing investors and several new private backers.